Medical and Pharmaceutical Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment The stock was up by about 200% during early trading hours Rowan DunneFebruary 6, 2025
Medical and Pharmaceutical Novocure scoops FDA approval for electric field lung cancer treatment device The Swiss oncology company's stock rose by over 33% as a result Rowan DunneOctober 16, 2024
Medical and Pharmaceutical Breath Diagnostics pioneers novel lung cancer breath test Development of a 'MicroReactor' has given the company a superior advantage over other breath analysis tech Rowan DunneAugust 23, 2024
Psychedelics Investors wince as FDA panel rejects proposal to approve ‘molly’ for PTSD therapy Despite rejection from the advisory committee, the FDA won't make its final decision on the matter until August Rowan DunneJune 5, 2024